A new study shows coibamide A has potent anti-cancer activity in mice and cell cultures that model
brain tumors and triple negative breast cancer, two
of the most aggressive and
difficult - to - treat
types of cancer.
The activation
of this signaling pathway progressively increased in different
types of gliomas, with the highest activity seen in patients with glioblastoma, a particularly
difficult - to - treat form
of brain cancer that represents approximately 15 percent
of all
brain tumors.